Isis Pharmaceuticals, Inc. (ISIS) Higher After Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts ISIS Hot Sheet
Price: $57.56 --0%
Financial Fact:
Basic net loss (in dollars per share): 0.06
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Basic net loss (in dollars per share): 0.06
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) are trading higher after the company reported Q2 EPS of ($0.01), $0.09 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $47.3 million versus the consensus estimate of $40.06 million.
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- ClearSign Technologies (CLIR) Tops Q2 EPS by 8c
- BILL posts stronger Q4 revenue, profit growth but sees slower fiscal 2027
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
